| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2022-04-27 22:16:32 UTC |
|---|
| Updated at | 2022-04-27 22:16:32 UTC |
|---|
| NP-MRD ID | NP0050860 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | Ellipticine |
|---|
| Description | Ellipticine, also known as NSC 71795, belongs to the class of organic compounds known as carbazoles. Carbazoles are compounds containing a three ring system containing a pyrrole ring fused on either side to a benzene ring. A organic heterotetracyclic compound that is pyridocarbazole carrying two methyl substituents at positions 5 and 11. Ellipticine is found in Aspidosperma subincanum, Bleekeria vitiensis, Elateriospermum tapos, Ochrosia acuminata, Ochrosia elliptica, Ochrosia moorei and Tabernaemontana coffeoides. Ellipticine was first documented in 2012 (PMID: 22802684). Ellipticine is a very strong basic compound (based on its pKa) (PMID: 22917556) (PMID: 23697684) (PMID: 23827542) (PMID: 23869776). |
|---|
| Structure | CC1=C2C=CN=CC2=C(C)C2=C1NC1=C2C=CC=C1 InChI=1S/C17H14N2/c1-10-14-9-18-8-7-12(14)11(2)17-16(10)13-5-3-4-6-15(13)19-17/h3-9,19H,1-2H3 |
|---|
| Synonyms | | Value | Source |
|---|
| Elliptisine | ChEBI | | NSC 71795 | ChEBI | | NSC-71795 | ChEBI | | Ellipticine tartrate | MeSH | | 5,11-Dimethyl-6H-pyrido(4,3-b)carbazole | MeSH | | Ellipticine hydrochloride | MeSH |
|
|---|
| Chemical Formula | C17H14N2 |
|---|
| Average Mass | 246.3130 Da |
|---|
| Monoisotopic Mass | 246.11570 Da |
|---|
| IUPAC Name | 5,11-dimethyl-6H-pyrido[4,3-b]carbazole |
|---|
| Traditional Name | ellipticine |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CC1=C2C=CN=CC2=C(C)C2=C1NC1=C2C=CC=C1 |
|---|
| InChI Identifier | InChI=1S/C17H14N2/c1-10-14-9-18-8-7-12(14)11(2)17-16(10)13-5-3-4-6-15(13)19-17/h3-9,19H,1-2H3 |
|---|
| InChI Key | CTSPAMFJBXKSOY-UHFFFAOYSA-N |
|---|
| Experimental Spectra |
|---|
|
| Not Available | | Predicted Spectra |
|---|
|
| | Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 13C NMR Spectrum (1D, 25 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as carbazoles. Carbazoles are compounds containing a three ring system containing a pyrrole ring fused on either side to a benzene ring. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Indoles and derivatives |
|---|
| Sub Class | Carbazoles |
|---|
| Direct Parent | Carbazoles |
|---|
| Alternative Parents | |
|---|
| Substituents | - Carbazole
- Isoquinoline
- Indole
- Benzenoid
- Pyridine
- Heteroaromatic compound
- Pyrrole
- Azacycle
- Organic nitrogen compound
- Organopnictogen compound
- Hydrocarbon derivative
- Organonitrogen compound
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|
| General References | - Wu Y, Sadatmousavi P, Wang R, Lu S, Yuan YF, Chen P: Self-assembling peptide-based nanoparticles enhance anticancer effect of ellipticine in vitro and in vivo. Int J Nanomedicine. 2012;7:3221-33. doi: 10.2147/IJN.S31858. Epub 2012 Jun 28. [PubMed:22802684 ]
- Stiborova M, Poljakova J, Martinkova E, Ulrichova J, Simanek V, Dvorak Z, Frei E: Ellipticine oxidation and DNA adduct formation in human hepatocytes is catalyzed by human cytochromes P450 and enhanced by cytochrome b5. Toxicology. 2012 Dec 16;302(2-3):233-41. doi: 10.1016/j.tox.2012.08.004. Epub 2012 Aug 16. [PubMed:22917556 ]
- Ghosh S, Kar A, Chowdhury S, Dasgupta D: Ellipticine binds to a human telomere sequence: an additional mode of action as a putative anticancer agent? Biochemistry. 2013 Jun 18;52(24):4127-37. doi: 10.1021/bi400080t. Epub 2013 Jun 4. [PubMed:23697684 ]
- Masood F, Chen P, Yasin T, Fatima N, Hasan F, Hameed A: Encapsulation of Ellipticine in poly-(3-hydroxybutyrate-co-3-hydroxyvalerate) based nanoparticles and its in vitro application. Mater Sci Eng C Mater Biol Appl. 2013 Apr 1;33(3):1054-60. doi: 10.1016/j.msec.2012.11.025. Epub 2012 Nov 28. [PubMed:23827542 ]
- Tmejova K, Krejcova L, Hynek D, Adam V, Babula P, Trnkova L, Stiborova M, Eckschlager T, Kizek R: Electrochemical study of ellipticine interaction with single and double stranded oligonucleotides. Anticancer Agents Med Chem. 2014 Feb;14(2):331-40. doi: 10.2174/18715206113139990316. [PubMed:23869776 ]
|
|---|